Urogen Pharma Ltd
(URGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | AZN | AMGN | GILD | BMY |
| Company | Urogen Pharma Ltd | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 20.26 | 205.64 | 362.66 | 151.89 | 60.11 |
| High | 21.62 | 206.71 | 370.23 | 156.95 | 60.95 |
| Low | 20.14 | 204.09 | 361.71 | 151.46 | 60.02 |
| Latest | 20.41 | 204.82 | 369.18 | 156.79 | 60.71 |
| Change | +0.20 | +0.30 | +5.50 | +4.98 | +0.85 |
| % Change | +0.99% | +0.15% | +1.51% | +3.28% | +1.42% |
| Volume | 518,937 | 1,638,100 | 1,029,752 | 3,338,053 | 5,156,524 |
| 20-Day Average Volume | 660,787 | 4,469,539 | 3,141,796 | 8,743,397 | 13,387,831 |
| Previous Close | 20.21 | 204.52 | 363.68 | 151.81 | 59.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 20.48 | 189.61 | 353.45 | 142.13 | 57.04 |
| 20-Day Raw Stochastic | 56.87% | 95.31% | 75.01% | 97.93% | 84.83% |
| 20-Day Relative Strength | 46.88 | 65.41 | 61.55 | 70.22 | 66.24 |
| Weighted Alpha | +45.84 | +48.95 | +33.77 | +61.96 | +24.42 |
| Today's Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 8% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 64% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.12% since 02/06/26 | +6.39% since 02/06/26 | -3.91% since 02/06/26 | +2.66% since 02/06/26 | -1.98% since 02/06/26 |
| Low | 19.65 on 02/12/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 22.25 on 02/10/26 | 206.71 on 02/13/26 | 384.62 on 02/09/26 | 157.29 on 02/11/26 | 61.63 on 02/09/26 |
| 1-Month | |||||
| %Chg | +3.23% since 01/13/26 | +8.65% since 01/13/26 | +13.87% since 01/13/26 | +28.58% since 01/13/26 | +8.66% since 01/13/26 |
| Low | 18.12 on 01/14/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 53.54 on 01/21/26 |
| High | 22.25 on 02/10/26 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -14.42% since 11/13/25 | +15.88% since 11/13/25 | +9.90% since 11/13/25 | +25.05% since 11/13/25 | +24.94% since 11/13/25 |
| Low | 18.12 on 01/14/26 | 176.56 on 11/14/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 30.00 on 11/26/25 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +1.79% since 08/13/25 | +31.75% since 08/13/25 | +27.63% since 08/13/25 | +30.31% since 08/13/25 | +26.98% since 08/13/25 |
| Low | 15.86 on 10/10/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 30.00 on 11/26/25 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 946,010 | 317,191,712 | 197,191,760 | 188,347,648 | 121,860,176 |
| Shares Outstanding, K | 46,809 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 90,400,000 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -126,870,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 27,480,000 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -33,350,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 1.32 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.69 on 11/06/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/09/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.28 | 16.78 | 19.12 | 9.74 |